Showing : 19–24 of 298
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22.
Steen DL, Umez-Eronini AA, Guo J, Khan N, Cannon CP.
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sharma A, Garg A, Elmariah S, Drachman D, Obiagwu C, Vallakati A, Sharma SK, Lavie CJ, Mukherjee D, Waksman R, Stefanini GG, Feres F, Marmur JD, Helft G.
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation
The AEIOU Trial Matthew R. Reynolds , J. Scott Allison , Andrea Natale , Ian L. Weisberg , Kenneth A. Ellenbogen , Mark Richards , Wen-Hua Hsieh , Julie Sutherland and Christopher P. Cannon
Understanding How to Improve Quality and Value for Patients With Acute Myocardial Infarction.
W asfy JH, Yeh RW.
Sorting out coronary stents, as time goes by.
Stefanini GG, Cutlip D.
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.
Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalan R, Spinar J, Park JG, White JA, Bohula E, Braunwald E; IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators ..